Astellas Pharma Pink Sheet Forecast - Accumulation Distribution
| ALPMY Stock | USD 13.91 0.46 3.20% |
Astellas Pink Sheet outlook is based on your current time horizon.
At this time, The relative strength index (RSI) of Astellas Pharma's share price is at 59. This suggests that the pink sheet is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Astellas Pharma, making its price go up or down. Momentum 59
Buy Extended
Oversold | Overbought |
Using Astellas Pharma hype-based prediction, you can estimate the value of Astellas Pharma from the perspective of Astellas Pharma response to recently generated media hype and the effects of current headlines on its competitors.
Astellas Pharma after-hype prediction price | USD 14.37 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Astellas |
Astellas Pharma Additional Predictive Modules
Most predictive techniques to examine Astellas price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Astellas using various technical indicators. When you analyze Astellas charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 292.37 | 276.95 |
| Check Astellas Pharma Volatility | Backtest Astellas Pharma | Information Ratio |
Astellas Pharma Trading Date Momentum
| On January 28 2026 Astellas Pharma was traded for 13.91 at the closing time. The highest daily price throughout the period was 14.37 and the lowest price was 13.84 . The daily volume was 7.5 K. The net trading volume on 01/28/2026 did not affect price variability. The overall trading delta to current closing price is 3.31% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Astellas Pharma to competition |
Other Forecasting Options for Astellas Pharma
For every potential investor in Astellas, whether a beginner or expert, Astellas Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Astellas Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Astellas. Basic forecasting techniques help filter out the noise by identifying Astellas Pharma's price trends.Astellas Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Astellas Pharma pink sheet to make a market-neutral strategy. Peer analysis of Astellas Pharma could also be used in its relative valuation, which is a method of valuing Astellas Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Astellas Pharma Market Strength Events
Market strength indicators help investors to evaluate how Astellas Pharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Astellas Pharma shares will generate the highest return on investment. By undertsting and applying Astellas Pharma pink sheet market strength indicators, traders can identify Astellas Pharma entry and exit signals to maximize returns.
| Accumulation Distribution | 276.95 | |||
| Daily Balance Of Power | (0.87) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 14.11 | |||
| Day Typical Price | 14.04 | |||
| Market Facilitation Index | 1.0E-4 | |||
| Price Action Indicator | (0.42) | |||
| Period Momentum Indicator | (0.46) | |||
| Relative Strength Index | 59.25 |
Astellas Pharma Risk Indicators
The analysis of Astellas Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Astellas Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting astellas pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.2 | |||
| Semi Deviation | 0.8888 | |||
| Standard Deviation | 1.61 | |||
| Variance | 2.58 | |||
| Downside Variance | 1.86 | |||
| Semi Variance | 0.7899 | |||
| Expected Short fall | (1.45) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Astellas Pharma
The number of cover stories for Astellas Pharma depends on current market conditions and Astellas Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Astellas Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Astellas Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Astellas Pharma Short Properties
Astellas Pharma's future price predictability will typically decrease when Astellas Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Astellas Pharma often depends not only on the future outlook of the potential Astellas Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Astellas Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.9 B | |
| Cash And Short Term Investments | 337.3 B |
Additional Tools for Astellas Pink Sheet Analysis
When running Astellas Pharma's price analysis, check to measure Astellas Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astellas Pharma is operating at the current time. Most of Astellas Pharma's value examination focuses on studying past and present price action to predict the probability of Astellas Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astellas Pharma's price. Additionally, you may evaluate how the addition of Astellas Pharma to your portfolios can decrease your overall portfolio volatility.